Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1825 of 2529 entries
View as:

Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL

Phase: N/A Priority: Normal
NCT ID: NCT04240704 Org: User:
Start: 09/07/20 End: 09/05/24 Due: 09/05/25

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02607774 Org: User:
Start: 12/17/15 End: 12/20/16 Due: 12/20/17

An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis

Phase: N/A Priority: Normal
NCT ID: NCT01743560 Org: User:
Start: 01/31/13 End: 08/15/16 Due: 08/15/17

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02605967 Org: User:
Start: 04/20/16 End: 02/19/21 Due: 02/19/22

Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04208178 Org: User:
Start: 07/16/20 End: 12/15/25 Due: 12/15/26

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT05126277 Org: User:
Start: 07/14/22 End: 07/15/30 Due: 07/15/31

Assess Bronchodilator Effect and Safety of Two Doses of QVM149 Compared to a Fixed Dose Combination of Salmeterol/Fluticasone in Patients With Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT03063086 Org: User:
Start: 01/21/17 End: 08/02/18 Due: 08/02/19

Pediatric Hypothalamic Obesity

Phase: N/A Priority: Normal
NCT ID: NCT00076362 Org: User:
Start: 03/31/04 End: - Due: -

Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00242567 Org: User:
Start: 12/31/05 End: 01/31/12 Due: 01/31/13

A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation

Phase: N/A Priority: Normal
NCT ID: NCT01028222 Org: User:
Start: 06/30/10 End: 12/31/14 Due: 12/31/15

A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab

Phase: N/A Priority: Normal
NCT ID: NCT01285466 Org: User:
Start: 01/31/11 End: 10/31/14 Due: 10/31/15

Ilaris NIS in Korea

Phase: N/A Priority: Normal
NCT ID: NCT06838143 Org: User:
Start: 04/30/25 End: 09/30/28 Due: 09/30/29

A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01278758 Org: User:
Start: 03/31/10 End: - Due: -

Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation

Phase: N/A Priority: Normal
NCT ID: NCT06444087 Org: User:
Start: 06/17/24 End: 03/30/27 Due: 03/30/28

A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT03549000 Org: User:
Start: 07/18/18 End: 10/17/22 Due: 10/17/23

A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China

Phase: N/A Priority: Normal
NCT ID: NCT05576792 Org: User:
Start: 01/13/23 End: 07/10/24 Due: 07/10/25

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT06470048 Org: User:
Start: 10/09/24 End: 07/15/30 Due: 07/15/31

Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib

Phase: N/A Priority: Normal
NCT ID: NCT00422825 Org: User:
Start: 06/30/06 End: 09/30/06 Due: 09/30/07

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03114319 Org: User:
Start: 05/26/17 End: 11/07/25 Due: 11/07/26

An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01281306 Org: User:
Start: 01/31/11 End: 12/31/11 Due: 12/31/12

Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00790036 Org: User:
Start: 07/24/09 End: 06/15/16 Due: 06/15/17

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

Phase: N/A Priority: Normal
NCT ID: NCT06514534 Org: User:
Start: 02/18/25 End: 12/01/28 Due: 12/01/29

A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis

Phase: N/A Priority: Normal
NCT ID: NCT03765788 Org: User:
Start: 01/30/19 End: 06/08/21 Due: 06/08/22

To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01568762 Org: User:
Start: 10/31/10 End: - Due: -

Digital Adherence Monitoring of Inhalative Therapy in Real- Life Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04656223 Org: User:
Start: 12/17/20 End: 01/20/23 Due: 01/20/24